Skip to main content
Clinical Trials/ISRCTN00424386
ISRCTN00424386
Completed
Not Applicable

Investigating the effectiveness of primary prevention strategies using extensively hydrolysed milk formula and probiotic supplements to prevent allergic disease in high risk infants: pilot factorial randomised controlled trial

Chief Scientist Office (UK)0 sites36 target enrollmentFebruary 27, 2008

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Chief Scientist Office (UK)
Enrollment
36
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 27, 2008
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Chief Scientist Office (UK)

Eligibility Criteria

Inclusion Criteria

  • 1\. Infants at high risk of atopy as judged by the mother, father or sibling having an allergic disease (asthma, allergic rhinitis, atopic dermatitis and food allergy)
  • 2\. Booked to give birth at the Royal Infirmary, Edinburgh

Exclusion Criteria

  • 1\. Do not give informed consent
  • 2\. Multiple pregnancy
  • 3\. Delivering prior to 37 weeks gestation

Outcomes

Primary Outcomes

Not specified

Similar Trials